compounders sue fda over ending semaglutide shortage FDA's Removal of and the Evolving Tirzepatide Decisions: What Need to Know An update from hims/hers: Compounded

There are clinical trials evaluating if these GLP-1 and multi-agonists can address neurodegeneration, addiction, inflammation, and beyond

Psychiatry 90 , 13311337, (2019)

Many compounds affecting neurological or hormonal pathways appear on the Department of Defenses prohibited dietary ingredient list and may lead to adverse findings in readiness or medical screenings

Novo Nordisk's Patient Assistance Program, Wegovy saving card, Ozempic saving card, and Rybelsus Saving Card help lower the cost for eligible patients

Some weight regain during the break is expected and acceptable

Reduced cravings is mentioned by many users, particularly cravings for sugary and fatty foods